Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Immunosuppressive Treatment for Primary Membranous Nephropathy in Adults With Nephrotic Syndrome." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431061/all/repview. Accessed 28 April 2024.
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431061/all/repview. Accessed April 28, 2024.
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431061/all/repview
Immunosuppressive Treatment for Primary Membranous Nephropathy in Adults With Nephrotic Syndrome [Internet]. In: Cochrane Abstracts. [cited 2024 April 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431061/all/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome
ID - 431061
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431061/all/repview
DB - Evidence Central
DP - Unbound Medicine
ER -